Hemispherx Biopharma Gets Response Letter From FDA

Reader Comments (0)

December 4, 2009 (FinancialWire) — Hemispherx Biopharma, Inc. (AMEX: HEB), received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) which describes specific additional recommendations related to the Ampligen(R) NDA.

In accordance with its 2008 "Complete Response" procedure, the FDA reviewers determined that they cannot approve the…

The content you are accessing is available to FinancialWire™ subscribers. We invite you to subscribe today, by selecting any of these special, introductory subscription packages:


New Site Visitors -- One week free trial, with the option to continue at the introductory rates listed here. Fee: Free   Three Months -- Complete access to all FinancialWire™ articles (past, present and future) for the next three months. Fee: $9.00
 
Today Only -- The option to access any day's FinancialWire™ edition is always available. Fee: $1.00   Six Months -- Complete access to all FinancialWire™ articles (past, present and future) for the next six months. Fee: $12.00
 
One Month -- Complete access to all FinancialWire™ articles (past, present and future) for the next month. Fee: $5.00   One Year -- Complete access to all FinancialWire™ articles (past, present and future) for the next year. Fee: $18.00

Front Page news from all FinancialWire™ editions is always available free of charge. Just select from the "Previous Issues" menu (at the upper-right of this page).


You must be logged in to purchase a subscription. If you do not have a FinancialWire™ account, it is free to register.


Please Note: You will not be automatically billed for any renewals. When your subscription expires, you will simply no longer be able to access all FinancialWire™ content until you renew your expired subscription.

After completing this subscription order, you will have the opportunity to review all your subscriber details before confirming your subscription.

FinancialWire™'s Privacy Policy: We will keep any personal/contact information provided to us completely confidential, and will not share any such information with anyone else. In addition, we will not contact you for any reason, unless you specifically request for us to do so.

Comments

Post a Comment

You must be logged in to post a comment. If you do not have a FinancialWire™ Reader Comments account, it is free to register.



Additional Headlines
MAKO Surgical Launches Application On Its RIO Robotic Arm Align Technology Launches Award Program For Clear Aligner Orthodontic Therapy
Generic Methadone Approved Mariner's Choice Delivers First Shipment To Caribbean
Integra Foundation Awards Grant To Support Pediatric Neurosurgery Resident Education Hana Biosciences Completes Enrollment in Pivotal Phase 2 rALLy Clinical Trial of Marqibo
LifeCycle Pharma Promotes Dr. William J. Polvino President, CEO Hemispherx Biopharma Gets Response Letter From FDA
Millennium Biotechnologies To Promote Resurgex Essential To Long-Term Care Market Compuware Gomez Publishes Retail Web And Mobile Performance Data For Cyber Monday
Zevotek Settles With Former CEO To Eliminate $490,000 Liability Magma Announces Talus-Based RTL-To-GDSII Reference Flow
Magma Announces Talus Design 1.1 and Talus RTL 1.1 Viosoft Announces Android Adoption Kit for MIPS-Based Digital Multimedia Designs
Himax Unveils Power-Saving iCT For TFT-LCD TVs And Monitors Catering Engros Drives Supply Chain Cost Savings, Delivers Sustainability Benefits With Manhattan Associates
Microsemi Presenting Global Technology Conference RF Micro Devices Presenting At Technology Conference
Fibre Channel Industry Association Sponsors Third Fibre Channel Over Ethernet Plugfest ITT Wins $9.7 Million Contract To Produce Netted Iridium Tactical Radio Handsets
Doral Energy Provides Operations Update Evolution Fuels Clarifies Current Outstanding Share Count
GMX Resources Plans To List Shares On New York Stock Exchange Hydrogenics Announces New Line Of Credit In Europe
Mechel Prolongs VTB Bank Loan Exide Technologies Powers African Solar Project
Marlin Expands Sales Team Anchor BanCorp Wisconsin Announces Investment Agreement
Anchor BanCorp Wisconsin Announces Investment Agreement Triangle Capital Declares $0.41 Cash Dividend
IMAX Corp. Presenting At California Dreamin' MAC Conference IMAX Corp. Presenting At California Dreamin' MAC Conference
Stryker Authorizes $750 Million Buyback Ensign Group Buys Arizona Nursing Facility
Rent-A-Center Amends Credit Line Corporate Office Properties Declares 39.25 Cent Dividend
Ziopharm Oncology To Launch Common Share Offering Beacon Power To Launch Common Share Offering
Bateman Named CFO Of Emeritus Mannatech Names Co-CEOs
Eastman Board Declares 44 Cent Dividend Enterprise Bancorp Raises $8.9 Million From Stock Sale
ConAgra Foods Declares Dividend Mace Security Sells Car Washes
Rambo Named To International Rectifier Board CTS Declares Dividend
Spina Named CEO Of Emerging Vision Hanesbrands Prices $500 Million Of Senior Notes
ValuEngine Upgrades Par Pharma, Aetna, Excentuals, China Eastern Airlines Sonoco Products Company Conference Call Today, 7:50 A.M.
Sirona Dental Systems Inc. Conference Call Today, 8:30 A.M. Falberg Named CFO Of Jazz Pharmaceuticals
PG&E To Buy Wind Energy Project OGE Energy Ups Dividend
FirstAlert(tm) Daily 12/4: Can S&P 500 Get Past 1100? Caterpillar And Colgate Palmolive Have Something In Common, Says Dr. Joe Duarte
BIO-key Holders OK Division Sale General Dynamics Wins $54 Million Marine Corps Contract
EastGroup Properties Declares 52 Cent Dividend Verizon Communications Declares Quarterly Dividend
AK Steel To Impose 2010 Steel Surcharges Hyperdynamics Plans Sale Of Shares, Warrants
Zerbe Named To Optimer Pharmaceuticals Board